Procurement Summary
Country : USA
Summary : Transcriptomics Sequencing and analysis in Liver Spheroids
Deadline : 22 Nov 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 110223924
Document Ref. No. : 75N95025Q00040
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
The National Center for Advancing Translational Sciences (NCATS) requires transcriptomics sequencing and analysis in liver spheroids. This requisition is requesting a contract to evaluate the RNA expression in liver toxicity associated with the systemic administration of antisense oligonucleotides (ASOs) in previously tested human, rat and mouse animal models. The project's phase one goal is to develop a predictive model of candidate ASO therapies' safety and acute toxicity. NCATS is seeking technical support to evaluate the safety and acute liver toxicity of candidate ASOs by checking the gene expression. The results from these studies, in conjunction with existing cell-based assays, will help better predict the safety of future candidate ASOs intended for clinical use. The objective of this contract is to generate proof-of-concept data for evaluating the ability of the 3D liver microtissue platform to predict the hepatoxicity of individual ASOs. If successful, this will represent a new means to screen ASOs for this type of toxicity that is cheaper, faster, and has high throughput. NCATS is seeking technical support to evaluate the safety and acute liver toxicity of candidate ASOs by checking the gene expression. The results from these studies, in conjunction with existing cell-based assays, will help better predict the safety of future candidate ASOs intended for clinical use.
Active Contract Opportunity
Notice ID : 75N95025Q00040
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Nov 15, 2024 09:48 am EST
Original Date Offers Due: Nov 22, 2024 03:00 pm EST
Inactive Policy: Manual
Original Inactive Date: Nov 23, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Rockville, MD 20850 USA
Documents
Tender Notice
D-FAR-52.pdf
Invoicing-Instructions-Without-IPP.pdf
B-Statement-of-Work.pdf
D.pdf
D.pdf
D.pdf
Invoicing-Instructions-With-IPP_Updated_04212022.pdf
D-CSS_75N95025Q00040.pdf